Cargando…
Pretreatment with AM1241 Enhances the Analgesic Effect of Intrathecally Administrated Mesenchymal Stem Cells
Mesenchymal stem cells have cannabinoid (CB) receptors type 1 and type 2 and can alleviate a variety of neuropathic pains, including chronic constriction injury (CCI). A selective CB2 receptor agonist is AM1241. In the present study, it was found that mice with CCI displayed a longer duration of mec...
Autores principales: | Xie, Junran, Ren, Jinxuan, Liu, Na, Wu, Chengwei, Xiao, Dongju, Luo, Huanyu, Du, Jingxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755285/ https://www.ncbi.nlm.nih.gov/pubmed/31611918 http://dx.doi.org/10.1155/2019/7025473 |
Ejemplares similares
-
CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats
por: Parlar, Ali, et al.
Publicado: (2020) -
Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia
por: Wilkerson, Jenny L, et al.
Publicado: (2012) -
AM1241 alleviates MPTP-induced Parkinson's disease and promotes the regeneration of DA neurons in PD mice
por: Shi, Jun, et al.
Publicado: (2017) -
Panobinostat (LBH589) combined with AM1241 induces cervical cancer cell apoptosis through autophagy pathway
por: Sheng, Bo, et al.
Publicado: (2023) -
JNK-IN-8 treatment alleviates lipopolysaccharide-induced acute lung injury via suppression of inflammation and oxidative stress regulated by JNK/NF-κB signaling
por: Du, Jingxian, et al.
Publicado: (2021)